A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
In high-transmission regions, protective clinical immunity to Plasmodium falciparum develops during the early years of life, limiting serious complications of malaria in young children. Pregnant women are an exception and are especially susceptible to severe P. falciparum infections resulting from the massive adhesion of parasitized erythrocytes to chondroitin sulphate A (CSA) present on placental syncytiotrophoblasts. Epidemiological studies strongly support the feasibility of an intervention strategy to protect pregnant women from disease. However, different parasite molecules have been associated with adhesion to CSA. In this work, we show that disruption of the var2csa gene of P. falciparum results in the inability of parasites to recover the CSA-binding phenotype. This gene is a member of the var multigene family and was previously shown to be composed of domains that mediate binding to CSA. Our results show the central role of var2CSA in CSA adhesion and support var2CSA as a leading vaccine candidate aimed at protecting pregnant women and their fetuses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“P. falciparum IE adhesion to CSA is mediated by the large (~350 kD) protein called VAR2CSA”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While gene knockout studies have demonstrated that VAR2CSA is required to maintain the CSA-binding phenotype [65]”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [65]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Malaria Parasites in Continuous Culture
Trager, W., & Jensen, J. B. (1976) · Science · doi:10.1126/science.781840 · Cited by 7,844
Genome sequence of the human malaria parasite Plasmodium falciparum
Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., et al. (2002) · Nature · doi:10.1038/nature01097 · Cited by 4,407
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108 · cited 2×
“Placental isolates are functionally distinct because they do not bind to CD36, but instead bind to CSA (Fried & Duffy, 1996) and, to some extent, to hyaluronic acid (Beeson et al, 2000).”
BackgroundAn analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed Central · Cited by 877
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702 · cited 2×
“Targeted disruption of the var2csa gene in FCR3 parasites It has been reported that var2csa is transcriptionally upregulated and expressed at the surface of CSA-binding parasites (Salanti et al, 2003, 2004; Gamain et al, 2005).”
BackgroundMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Rapid switching to multiple antigenic and adhesive phenotypes in malaria
Roberts, D. J., Craig, Berendt, A. R., Pinches, R., Nash, G., Marsh, K., & Newbold, C. I. (1992) · Nature · doi:10.1038/357689a0 · Cited by 619 · cited 1×
“Switching of var genes occurs in in vitrocultured parasites, and variants that are able to adhere to a large number of different host receptors have been isolated using receptor-specific panning assays (Roberts et al, 1992; Scherf et al, 1998).”
MethodScherf, A., Hernandez-Rivas, R., Buffet, P., Bottius, E., Benatar, C., Pouvelle, B., Gysin, J., & Lanzer, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5418 · Cited by 610
Self-citationEvidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
Cited by
Malaria: progress, perils, and prospects for eradication
Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H. I., Alonso, P. L., Collins, F. H., & Duffy, P. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33996 · Cited by 709
“Placental parasites express distinct genes and proteins (103), including an IE variant surface protein called VAR2CSA (104) that is required for adhesion to CSA in some parasite lines (105) and that binds CSA in vitro (106).”
Malaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628
Antigenic variation in Plasmodium falciparum.
Biggs, B. A., Goozé, L., Wycherley, K., Wollish, W., Southwell, B., Leech, J. H., & Brown, G. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9171 · Cited by 505
Antigenic Variation in Plasmodium falciparum
Scherf, A., Lopez-Rubio, J. J., & Riviere, L. (2008) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.080706.093134 · Cited by 447
“The second study showed that pairing a var promoter in its natural location with another promoter of a selectable drug marker gene approximately 4 kb downstream of the transcriptional start site leads to a constitutive transcription (truncated transcript of 7 kb) and uncoupling of the var promoter from mutually exclus…”
BackgroundSelf-citationPlasmodium falciparum Erythrocyte Membrane Protein 1 Diversity in Seven Genomes – Divide and Conquer
Rask, T. S., Hansen, D. A., Theander, T. G., Gorm Pedersen, A., & Lavstsen, T. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000933 · Cited by 372
“This relationship is best illustrated by the malaria syndrome occurring in pregnant women, which is precipitated by the accumulation, in the placenta, of parasites expressing VAR2CSA that mediates binding to proteoglycans on syncytiotrophoblasts [17–21].”
BackgroundLopez‐Rubio, J. J., Gontijo, A. M., Nunes, M. C., Issar, N., Hernandez Rivas, R., & Scherf, A. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.06009.x · Cited by 247
“We used a recently published receptor-panning assay, which allows the selection of a single var gene (var2csa) to be active or stably repressed (Viebig et al., 2005).”
MethodSelf-citationKraemer, S. M., Kyes, S. A., Aggarwal, G., Springer, A. L., Nelson, S. O., Christodoulou, Z., Smith, L. M., Wang, W., Levin, E., Newbold, C. I., et al. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-45 · Cited by 203
“The chromosomal location of var2csa was determined in [78].”
BackgroundDzikowski, R., Frank, M., & Deitsch, K. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020022 · Cited by 197
“The second example is from a transgenic line in which the var2csa gene has been disrupted [ 26 ].”
BackgroundMalaria in Pregnancy: Linking Immunity and Pathogenesis to Prevention
Rogerson, S. J., Mwapasa, V., & Meshnick, S. R. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.77.6.suppl.14 · Cited by 188
Kyes, S. A., Kraemer, S. M., & Smith, J. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00173-07 · Cited by 170
Chan, J.-A., Fowkes, F. J. I., & Beeson, J. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1614-3 · Cited by 168
“A variant expressed by 3D7 and FCR3 parasites, SURFIN4.”
BackgroundSrivastava, A., Gangnard, S., Round, A., Dechavanne, S., Juillerat, A., Raynal, B., Faure, G., Baron, B., Ramboarina, S., Singh, S. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000951107 · Cited by 149
Self-citationSirima, S. B., Richert, L., Chêne, A., Konate, A. T., Campion, C., Dechavanne, S., Semblat, J.-P., Benhamouda, N., Bahuaud, M., Loulergue, P., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30739-x · Cited by 124
Self-citationInvestigating the Host Binding Signature on the Plasmodium falciparum PfEMP1 Protein Family
Janes, J. H., Wang, C., Levin-Edens, E., Vigan-Womas, I., Guillotte-Blisnick, M., Melcher, M., Mercereau‐Puijalon, O., & Smith, J. D. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002032 · Cited by 148
“Although VAR2CSA appears to be unique in its ability to confer high-affinity binding to CSA in the placenta [60,61,63], it offers a paradigm for the role of specific PfEMP1s in disease.”
Nunes, M. C., Goldring, J. P. D., Doerig, C., & Scherf, A. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05521.x · Cited by 147
“During first pregnancy a particular var gene called var2CSA is activated (Salanti et al., 2003; Gamain et al., 2005; Viebig et al., 2005), leading to the massive sequestration of IEs in the placenta through the binding to chondroitin sulphate A (CSA) expressed by syncytiotrophoblastic cells (Fried and Duffy, 1996).”
BackgroundSelf-citationKhunrae, P., Dahlbäck, M., Nielsen, M. A., Andersen, G., Ditlev, S. B., Resende, M., Pinto, V. V., Theander, T. G., Higgins, M. K., & Salanti, A. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.040 · Cited by 121
“Rat antibodies induced by a recombinant DBL4ɛ protein from VAR2CSA of FCR3 are able to inhibit IE binding to the CSA of the homologous parasite FCR3 by 90%.14 Since the CSA-binding region of VAR2CSA has not been defined, it is not clear how the inhibitory DBL4ɛ antibodies act to abrogate the interaction with CSA.”
BackgroundInfluentialMolecular Epidemiology of Malaria
Conway, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-06 · Cited by 143
“falciparum var gene (var2csa) that encodes a variant of PfEMP1 is responsible (170, 193) and is expressed at high levels in most infections of pregnant women (61, 190) but only occasionally in infections of others (190).”
BackgroundBockhorst, J., Lu, F., Janes, J. H., Keebler, J., Gamain, B., Awadalla, P., Su, X.-Z., Samudrala, R., Jojic, N., & Smith, J. D. (2007) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.06.007 · Cited by 117
“VAR2CSA contains multiple CSA binding Duffy binding-like (DBL) domains [13] and appears to be one of the few or only PfEMP1 proteins mediating CSA binding because parasites in which the gene is experimentally disrupted lose the ability to adhere strongly to CSA [14] [15].”
Self-citationBarfod, L., Bernasconi, N. L., Dahlbäck, M., Jarrossay, D., Andersen, P. H., Salanti, A., Ofori, M. F., Turner, L., Resende, M., Nielsen, M. A., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05503.x · Cited by 110
“…CSA, which is thought to be a critical element in the pathogenesis of PAM (Fried and Duffy, 1996), is mediated by VAR2CSA as documented by recent knockout studies (Viebig et al., 2005; Duffy et al., 2006b), and several CSA-adhesive domains have been identified in the antigen (Gamain et al., 2005).”
BackgroundDuffy, M. F., Maier, A. G., Byrne, T. J., Marty, A. J., Elliott, S. R., O’Neill, M. T., Payne, P. D., Rogerson, S. J., Cowman, A. F., Crabb, B. S., et al. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.03.006 · Cited by 126
Amulic, B., Salanti, A., Lavstsen, T., Nielsen, M. A., & Deitsch, K. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000256 · Cited by 114
Frank, M., Dzikowski, R., Costantini, D., Amulic, B., Berdougo, E., & Deitsch, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513067200 · Cited by 115
Transcribed var Genes Associated with Placental Malaria in MalawianWomen
Duffy, M. F., Caragounis, A., Noviyanti, R., Kyriacou, H. M., Choong, E. K., Boysen, K., Healer, J., Rowe, J. A., Molyneux, M. E., Brown, G. V., et al. (2006) · Infection and Immunity · doi:10.1128/iai.01978-05 · Cited by 104
“varCSA is not associated with adhesion to CSA (9, 10, 25, 35, 40, 41).”
BackgroundSingh, K., Gittis, A. G., Nguyen, P., Gowda, D. C., Miller, L. H., & Garboczi, D. N. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1479 · Cited by 99
“Furthermore, the ability of infected erythrocytes to adhere to CSA is los”
Basic Structure of the Villous Trees
Benirschke, K., Burton, G. J., & Baergen, R. N. (2012) · Springer eBooks · doi:10.1007/978-3-642-23941-0_6 · Cited by 107
The Structure of a Chondroitin Sulfate-binding Domain Important in Placental Malaria
Higgins, M. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800086200 · Cited by 100
Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
Ndam, N. T., Denoeud-Ndam, L., Doritchamou, J., Viwami, F., Salanti, A., Nielsen, M. A., Fievet, N., Massougbodji, A., Luty, A. J. F., & Deloron, P. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2105.141626 · Cited by 98
“The demonstration that parasites that have the var2csa knockout gene irreversibly lose the ability to adhere to CSA (18), as well as the ability of VAR2CSA to induce antibodies that inhibit adherence of placental infective erythrocytes to CSA in vitro, strongly argue for use of VAR2CSA as a vaccine against placental m…”
Dahlbäck, M., Rask, T. S., Andersen, P. H., Nielsen, M. A., Ndam, N. T., Resende, M., Turner, L., Deloron, P., Hviid, L., Lund, O., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020124 · Cited by 98
Nielsen, M. A., Pinto, V. V., Resende, M., Dahlbäck, M., Ditlev, S. B., Theander, T. G., & Salanti, A. (2009) · Infection and Immunity · doi:10.1128/iai.00159-09 · Cited by 92
“Parasite clones where the var2csa gene is disrupted lose the ability to bind CSA (25).”
BackgroundGenetic and Epigenetic Mechanisms Underlying Cell-Surface Variability in Protozoa and Fungi
Verstrepen, K. J., & Fink, G. R. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134156 · Cited by 90
“PfEMP1 proteins confer adhesion of infected cells to (healthy) host tissues, blood cells and chondroitin sulphate A, a ubiquitous extracellular glycosaminoglycan (108, 128, 147).”
BackgroundDesigning a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
“While gene knockout studies have demonstrated that VAR2CSA is required to maintain the CSAbinding phenotype [65], other genes and proteins are upregulated in placental parasites and therefore might contribute to the binding phenotype or to placental malaria pathogenesis as well.”
BackgroundPlasmodium falciparum FIKK Kinase Members Target Distinct Components of the Erythrocyte Membrane
Nunes, M. C., Okada, M., Scheidig‐Benatar, C., Cooke, B. M., & Scherf, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011747 · Cited by 98
“Southern blot were performed, as described previously [39].”
MethodSelf-citationVaccine development against malaria
Matuschewski, K. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.05.004 · Cited by 90
Var2CSA minimal CSA binding region is located within the N-terminal region
Srivastava, A., Gangnard, S., Dechavanne, S., Amirat, F., Lewit Bentley, A., Bentley, G. A., & Gamain, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020270 · Cited by 76
“clones either did not recover the CSA-binding phenotype [15] or”
BackgroundSelf-citationDefault Pathway of var2csa Switching and Translational Repression in Plasmodium falciparum
Mok, B. W.-Y., Ribacke, U., Rasti, N., Kironde, F., Chen, Q., Nilsson, P., & Wahlgren, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001982 · Cited by 85
“VAR2CSA, which is also of particular interest for the present study, has previously been identified as the major PfEMP1 implicated in PAM and shown to interact with chondroitin sulphate A (CSA), non-immune immunoglobulins and possibly other host-receptors, engendering placental sequestration and pathogenesis in PAM [4…”
BackgroundDisruption of Var2csa Gene Impairs Placental Malaria Associated Adhesion Phenotype
Viebig, N. K., Levin, E., Dechavanne, S., Rogerson, S. J., Gysin, J., Smith, J. D., Scherf, A., & Gamain, B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000910 · Cited by 79
Self-citationHviid, L. (2010) · Human Vaccines · doi:10.4161/hv.6.1.9602 · Cited by 75
Variant antigen gene expression in malaria
Dzikowski, R., Templeton, T. J., & Deitsch, K. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00760.x · Cited by 80
“Several transgenic parasite lines have been generated in which the interactions between a var promoter and intron have been disrupted (Gannoun-Zaki et al., 2005; Viebig et al., 2005; Frank et al., 2006).”
BackgroundPacheco, M. A., Cranfield, M. R., Cameron, K., & Escalante, A. A. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-328 · Cited by 88
“Pregnancy-associated malaria (PAM) is related to the expression of a var gene, known as var2CSA [45-48].”
BackgroundVAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria
HVIID, L., & SALANTI, A. (2007) · Parasitology · doi:10.1017/s0031182007000121 · Cited by 69
“2005) and that disruption of var2csa interferes with the ability to acquire the CSA-adhering phenotype further supports the PAM-relevance of this sub-family (Viebig et al. 2005; Duffy et al. 2006).”
BackgroundResultBirch, C. M., Hou, H. W., Han, J., & Niles, J. C. (2015) · Scientific Reports · doi:10.1038/srep11347 · Cited by 71
Rasti, N., Namusoke, F., Chêne, A., Chen, Q., Staalsoe, T., Klinkert, M.-Q., Mirembe, F., Kironde, F., & Wahlgren, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601519103 · Cited by 69
Epigenetic Dysregulation of Virulence Gene Expression in Severe Plasmodium falciparum Malaria
Merrick, C. J., Huttenhower, C., Buckee, C. O., Amambua‐Ngwa, A., Gomez‐Escobar, N., Walther, M., Conway, D. J., & Duraisingh, M. T. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis239 · Cited by 75
“genes are associated with symptomatic malaria in pregnancy [16, 17].”
BackgroundRalph, S. A., Bischoff, E., Mattei, D., Sismeiro, O., Dillies, M.-A., Guigon, G., Coppee, J.-Y., David, P. H., & Scherf, A. (2005) · Genome Biology · doi:10.1186/gb-2005-6-11-r93 · Cited by 67
“The probes corresponding to this open reading frame (ORF) indicated a 5 to 9-fold upregulation of this gene in FCR3-CSA parasites compared with FCR3-CD36, but the AATL for this gene is still relatively low (Additional data file 1), and varA4-tres transcript is not detected in CSA-panned parasites by Northern blot usin…”
BackgroundInfluentialSelf-citationBigey, P., Gnidehou, S., Doritchamou, J., Quiviger, M., Viwami, F., Couturier, A., Salanti, A., Nielsen, M. A., Scherman, D., Deloron, P., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir499 · Cited by 63
“clearly been demonstrated [9], and accumulated evidence shows that naturally acquired antibodies against VAR2CSA play a major role in the protective immunity to PM [10, 11].”
BackgroundBaratin, M., Roetynck, S., Pouvelle, B., Lemmers, C., Viebig, N. K., Johansson, S., Bierling, P., Scherf, A., Gysin, J., Vivier, É., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000228 · Cited by 68
“2A5 is a var2csa disruption mutant of FCR3 that is unable to recover the CSA-binding phenotype [24].”
BackgroundMethodInfluentialSelf-citationBarfod, L., Dobrilovic, T., Magistrado, P., Khunrae, P., Viwami, F., Bruun, J., Dahlbäck, M., Bernasconi, N. L., Fried, M., John, D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002390 · Cited by 62
“encoding var2csa gene has been knocked out lose or show greatly reduced capacity to acquire this adhesion phenotype (7, 8).”
BackgroundCharacterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies
Avril, M., Gamain, B., Lépolard, C., Viaud, N., Scherf, A., & Gysin, J. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.09.005 · Cited by 61
Self-citationLarsen, M. D., Lopez-Perez, M., Dickson, E. K., Ampomah, P., Ndam, N. T., Nouta, J., Koeleman, C. A. M., Ederveen, A. L. H., Mordmüller, B. G., Salanti, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26118-w · Cited by 67
Khunrae, P., Philip, J. M. D., Bull, D. R., & Higgins, M. K. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.08.027 · Cited by 61
Rovira-Vallbona, E., Moncunill, G., Bassat, Q., Aguilar, R., Machevo, S., Puyol, L., Quintó, L., Menéndez, C., Chitnis, C. E., Alonso, P. L., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-181 · Cited by 70
“IgG were also measured against four laboratory clones with different receptor binding phenotypes: R29 (rosetting, [35]), ITGICAM (ICAM-1, [36]), FCR3CSA (CSA, [37]) and E8BCD36 (CD36, [38]).”
MethodGenetics of antigenic variation in Plasmodium falciparum
Dzikowski, R., & Deitsch, K. (2009) · Current Genetics · doi:10.1007/s00294-009-0233-2 · Cited by 68
“A particular var gene, called var2csa, is found within the genomes of most or all wildtype parasites (Trimnell et al. 2006) and is thought to encode a form of PfEMP1 that speciWcally binds to the placental receptor chondroitin sulfate A (CSA) (Salanti et al. 2003; Viebig et al. 2005).”
Hommel, M., Elliott, S. R., Soma, V., Kelly, G., Fowkes, F. J. I., Chesson, J. M., Duffy, M. F., Bockhorst, J., Avril, M., Mueller, I., et al. (2010) · Infection and Immunity · doi:10.1128/iai.01365-09 · Cited by 57
“Disruption of var2csa inhibits the ability of IEs to bind to CSA (22, 58), and antibody binding to the surface of CSA-binding parasites is greatly reduced when PfEMP1 expression is inhibited (39, 40).”
BackgroundEpigenetic Variation and Regulation in Malaria Parasites
Duraisingh, M. T., & Skillman, K. M. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090817-062722 · Cited by 62
VAR2CSA Expression on the Surface of Placenta‐Derived Plasmodium falciparum–Infected Erythrocytes
Magistrado, P., Salanti, A., Tuikue Ndam, N. G., Mwakalinga, S. B., Resende, M., Dahlbäck, M., Hviid, L., Lusingu, J., Theander, T. G., & Nielsen, M. A. (2008) · The Journal of Infectious Diseases · doi:10.1086/591502 · Cited by 61
Oxidative insult can induce malaria-protective trait of sickle and fetal erythrocytes
Cyrklaff, M., Srismith, S., Nyboer, B., Burda, K., Hoffmann, A., Lasitschka, F., Adjalley, S. H., Bisseyé, C., Simporè, J., Mueller, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms13401 · Cited by 64
“2d), a model receptor for cytoadhesion of parasitized erythrocytes in the placental intervillous space 25 .”
Self-citationTempleton, T. J. (2009) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2009.04.003 · Cited by 60
Marty, A. J., Thompson, J. K., Duffy, M. F., Voss, T. S., Cowman, A. F., & Crabb, B. S. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05364.x · Cited by 62
“E8B-pHHM and CS2-pHHM were analysed for expression of the var gene var2csa, which mediates binding to CSA (Salanti et al., 2003; Viebig et al., 2005; Duffy et al., 2006).”
Voss, T. S., Tonkin, C. J., Marty, A. J., Thompson, J. K., Healer, J., Crabb, B. S., & Cowman, A. F. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05899.x · Cited by 60
“However, Viebig et al. (2005) found that integration into the var2csa locus of a hdhfr-resistance cassette under control of the calmodulin promoter led to the constitutive activation, rather than silencing, of upsEdriven transcription of the truncated var2csa gene.”
BackgroundCharnaud, S. C., Dixon, M. W. A., Nie, C. Q., Chappell, L., Sanders, P. R., Nebl, T., Hanssen, E. G., Berriman, M., Chan, J.-A., Blanch, A. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181656 · Cited by 59
“Neither parasite line was able to efficiently cytoadhere under high flow conditions, indicative of the reduced cytoadhesive properties of placental binding parasites such as CS2 in general [63].”
BackgroundSelf-citationFRANK, M., & Deitsch, K. (2006) · International Journal for Parasitology · doi:10.1016/j.ijpara.2006.05.007 · Cited by 60
Beeson, J. G., Ndungu, F., Persson, K. E. M., Chesson, J. M., Kelly, G. L., Uyoga, S., Hallamore, S. L., Williams, T. N., Reeder, J. C., Brown, G. V., et al. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.22 · Cited by 52
Plasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression
Tuikue Ndam, N., Bischoff, E., Proux, C., Lavstsen, T., Salanti, A., Guitard, J., Nielsen, M. A., Coppée, J.-Y., Gaye, A., Theander, T., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001855 · Cited by 48
“falciparum iEs and parasites from infected placentas [4,11,12,13,14].”
BackgroundMagistrado, P. A., Minja, D., Doritchamou, J., Tuikue Ndam, N., John, D., Schmiegelow, C., Massougbodji, A., Dahlbäck, M., Ditlev, S. B., Pinto, V. V., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.10.080 · Cited by 49
Pregnancy-associated malaria: Parasite binding, natural immunity and vaccine development
Gamain, B., Smith, J. D., Viebig, N. K., Gysin, J., & Scherf, A. (2006) · International Journal for Parasitology · doi:10.1016/j.ijpara.2006.11.011 · Cited by 53
“Even after multiple rounds of selection, FCR3Dvar2CSA mutant clones did not recover the CSAbinding phenotype (Viebig et al., 2005) or switched to low affinity CSA binders that no longer reacted in a gender-specific manner with multigravid sera (Duffy et al.”
Self-citationResende, M., Ditlev, S. B., Nielsen, M. A., Bodevin, S., Bruun, S., Pinto, V. V., Clausen, H., Turner, L., Theander, T. G., Salanti, A., et al. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.02.022 · Cited by 51
Chapter 1 Strain Theory of Malaria
McKenzie, F. E., Smith, D. L., O’Meara, W. P., & Riley, E. M. (2008) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)00201-7 · Cited by 48
“Parasites sequestering in placenta and giving rise to pregnancyassociated malaria do share a common phenotype (adherence of infected red blood cells to chondroitin sulphate A via PfEMP-1) and some candidate var genes responsible for this phenotype have been identified (Francis et al., 2007; Salanti et al., 2004; Viebi…”
BackgroundVigan-Womas, I., Guillotte-Blisnick, M., Juillerat, A., Vallières, C., Lewit‐Bentley, A., Tall, A., Baril, L., Bentley, G. A., & Mercereau‐Puijalon, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016544 · Cited by 45
Montgomery, J. L., Milner, D. A., Tse, M. T., Njobvu, A., Kayira, K., Dzamalala, C. P., Taylor, T. E., Rogerson, S. J., Craig, A. G., & Molyneux, M. E. (2006) · The Journal of Infectious Diseases · doi:10.1086/504689 · Cited by 49
“hyaluronic acid [7–10].”
Bancells, C., & Deitsch, K. (2013) · Molecular Microbiology · doi:10.1111/mmi.12379 · Cited by 53
“This PfEMP1, called VAR2CSA, recognizes the proteoglycan chondroitin sulphate A (CSA), a molecule that is highly expressed on the surface of the syncytiotrophoblasts of the placenta (Salanti et al., 2004; Viebig et al., 2005).”
BackgroundNatural killer cells and malaria
Roetynck, S., Baratin, M., Johansson, S., Lemmers, C., Vivier, É., & Ugolini, S. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00446.x · Cited by 60
“The binding to CSA can be mediated by means of the DBLg domains of the var genes (84, 85).”
BackgroundHelms, G., Dasanna, A. K., Schwarz, U. S., & Lanzer, M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12142 · Cited by 54
Self-citationSanchez, C. P., Karathanasis, C., Sanchez, R., Cyrklaff, M., Jäger, J., Buchholz, B. M., Schwarz, U. S., Heilemann, M., & Lanzer, M. (2019) · Communications Biology · doi:10.1038/s42003-019-0429-z · Cited by 51
Self-citationRieger, H., Yoshikawa, H., Quadt, K. A., Nielsen, M. A., Sanchez, C. P., Salanti, A., Tanaka, M., & Lanzer, M. (2014) · Blood · doi:10.1182/blood-2014-03-561019 · Cited by 52
Self-citationFernandez, P., Viebig, N. K., Dechavanne, S., Lépolard, C., Gysin, J., Scherf, A., & Gamain, B. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-170 · Cited by 43
“Importantly, var2csa knock-out parasites revealed that no other parasite ligand can promote massive adhesion in the placenta [ 21- 23 ].”
BackgroundSelf-citationSeveral domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Salanti, A., Resende, M., Ditlev, S. B., Pinto, V. V., Dahlbäck, M., Andersen, G., Manczak, T., Theander, T. G., & Nielsen, M. A. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-11 · Cited by 42
“VAR2CSA is expressed on the surface of IE panned on CSA and on IE isolated from infected placentas [12,13] and parasite clones where the var2csa gene is disrupted lose the ability to bind CSA [14].”
Avril, M., Hathaway, M. J., Srivastava, A., Dechavanne, S., Hommel, M., Beeson, J. G., Smith, J. D., & Gamain, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016622 · Cited by 40
“Furthermore, VAR2CSA appears to be a major target of the antibody mediated immune response in pregnant women [15,20], and parasites in which var2csa is genetically disrupted largely lose the ability to bind to CSA [12,17] and placental syncytiotrophoblast [21], suggesting it is the primary var gene responsible for pla…”
BackgroundSelf-citationMalaria in Pregnancy and the Newborn
Rogerson, S. J. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0981-7_12 · Cited by 43
“The parasite genome contains 60 var genes, each encoding a different red cell surface protein, but when var2sca is knocked out, parasites lose the ability to bind to CSA or to placenta (Duffy et al., 2006b; Viebig et al., 2005; Yosaatmadja et al., 2008).”
BackgroundProgress and Insights Toward an Effective Placental Malaria Vaccine
Gamain, B., Chêne, A., Viebig, N. K., Ndam, N. T., & Nielsen, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.634508 · Cited by 46
Self-citationHemoglobin S and C affect protein export in Plasmodium falciparum-infected erythrocytes
Kilian, N., Srismith, S., Dittmer, M., Ouermi, D., Bisseyé, C., Simporè, J., Cyrklaff, M., Sanchez, C. P., & Lanzer, M. (2015) · Biology Open · doi:10.1242/bio.201410942 · Cited by 48
“The var2csa knockout strain FCR3Dvar2CSA, which exhibits a null CSA-binding phenotype, has been described (Viebig et al., 2005).”
BackgroundMethodResultInfluentialSelf-citationAvril, M., Cartwright, M. M., Hathaway, M. J., Hommel, M., Elliott, S. R., Williamson, K., Narum, D. L., Duffy, P. E., Fried, M., Beeson, J. G., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00410-09 · Cited by 39
“Parasites in which var2csa is genetically disrupted lose the ability to bind to CSA (16, 60), suggesting that VAR2CSA is the only or the major PfEMP1 variant associated with CSA binding.”
BackgroundClinical development of placental malaria vaccines and immunoassays harmonization: a workshop report
Chêne, A., Houard, S., Nielsen, M. A., Hundt, S., D’Alessio, F., Sirima, S. B., Luty, A. J. F., Duffy, P., Leroy, O., Gamain, B., et al. (2016) · Malaria Journal · doi:10.1186/s12936-016-1527-8 · Cited by 39
Self-citationFunctional Analysis of Sirtuin Genes in Multiple Plasmodium falciparum Strains
Merrick, C. J., Jiang, R. H. Y., Skillman, K. M., Samarakoon, U., Moore, R. M., Dzikowski, R., Ferdig, M. T., & Duraisingh, M. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118865 · Cited by 41
“Var gene expression was assessed using a 3D7-specific primer subset [12] for 3D7 and NF54 or an FCR-3-specific subset for the var family in FCR-3 [63], which contains similar, but not identical, numbers of upsA, B and C type var genes.”
MethodMelcher, M., Muhle, R., Henrich, P. P., Kraemer, S. M., Avril, M., Vigan-Womas, I., Mercereau‐Puijalon, O., Smith, J. D., & Fidock, D. A. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01481.x · Cited by 42
“…exchange strategies have been used to disrupt specific var genes by single or double recombination (Andrews et al., 2003; Horrocks et al., 2004; Viebig et al., 2005), but the large size of these genes and their switching properties have hindered structure-function studies and phenotypic…”
Resende, M., Nielsen, M. A., Dahlbäck, M., Ditlev, S. B., Andersen, P., Sander, A. F., Ndam, N. T., Theander, T. G., & Salanti, A. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-104 · Cited by 36
“Disruption of the var2csa gene causes the loss of the IE's ability to bind CSA [23].”
BackgroundBordbar, B., Ndam, N. T., Bigey, P., Doritchamou, J., Scherman, D., & Deloron, P. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.065 · Cited by 43
Zhang, Q., Zhang, Y., Huang, Y., Xue, X., Yan, H., Sun, X., Wang, J., McCutchan, T. F., & Pan, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020591 · Cited by 41
“The first has been described by Kraemer and Robinson [35,36], and the second association was well studied with parasites involved in pregnancy-associated malaria (PAM) [37,38].”
BackgroundChêne, A., Gangnard, S., Dechavanne, C., Dechavanne, S., Srivastava, A., Tétard, M., Hundt, S., Leroy, O., Havelange, N., Viebig, N. K., et al. (2018) · npj Vaccines · doi:10.1038/s41541-018-0064-6 · Cited by 36
Self-citationBeeson, J. G., Andrews, K. T., Boyle, M. J., Duffy, M. F., Choong, E. K., Byrne, T. J., Chesson, J. M., Lawson, A. M., & Chai, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700231200 · Cited by 39
Goel, S., Valiyaveettil, M., Achur, R. N., Goyal, A., Mattei, D., Salanti, A., Trenholme, K. R., Gardiner, D. L., & Gowda, D. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002568107 · Cited by 42
Fernandez, P., Petres, S., Mécheri, S., Gysin, J., & Scherf, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012558 · Cited by 36
“The use of VAR2CSA as a vaccine candidate to prevent PAM is hampered by its high molecular weight together with its hydrophobic and cysteine-rich sequence as major restrictions for production of sufficient functional full-length recombinant protein.”
BackgroundInfluentialSelf-citationViebig, N. K., Nunes, M. C., Scherf, A., & Gamain, B. (2005) · Experimental Parasitology · doi:10.1016/j.exppara.2005.09.007 · Cited by 41
Self-citationDoritchamou, J. Y. A., Herrera, R., Aebig, J. A., Morrison, R., Nguyen, V., Reiter, K., Shimp, R. L., MacDonald, N. J., Narum, D. L., Fried, M., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw197 · Cited by 35
The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria
Hviid, L. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.113 · Cited by 34
Blood-Stage Malaria Parasite Antigens: Structure, Function, and Vaccine Potential
Salinas, N. D., Tang, W. K., & Tolia, N. H. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.018 · Cited by 39
Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption
Avril, M., Benjamin, M., Dols, M.-M., & Smith, J. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-49530-1 · Cited by 32
Trends of malaria infection in pregnancy in Ghana over the past two decades: a review
Osarfo, J., Ampofo, G. D., & Tagbor, H. K. (2022) · Malaria Journal · doi:10.1186/s12936-021-04031-3 · Cited by 42
“Paucigravid women have no or insufficient antibodies to counter placental binding by infected red blood cells expressing specific surface antigens and are thus more likely to have placental infections leading to severe adverse outcomes [66].”
BackgroundNuclear run-on analysis of var gene expression in Plasmodium falciparum
Schieck, E., Pfahler, J. M., Sanchez, C. P., & Lanzer, M. (2007) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.02.004 · Cited by 36
Self-citationNielsen, M. A., Resende, M., Alifrangis, M., Turner, L., Hviid, L., Theander, T. G., & Salanti, A. (2007) · Experimental Parasitology · doi:10.1016/j.exppara.2007.03.002 · Cited by 33
“Disruption of the var2csa gene results in loss of the ability of the IE to bind CSA (Viebig et al., 2005; Duffy et al., 2006a).”
Merrick, C. J., Dzikowski, R., Imamura, H., Chuang, J. H., Deitsch, K., & Duraisingh, M. T. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.06.012 · Cited by 34
“also a unique upsE gene encoding the unusual PfEMP1 protein VAR2CSA, which adheres to the placental marker chondroitin sulphate A (CSA) and is likely to play a major role in pregnancy malaria (Salanti et al., 2003; Viebig et al., 2005).”
Background
Metadata
- Authors
- Viebig, N. K., Gamain, B., Scheidig, C., Lépolard, C., Przyborski, J., Lanzer, M., Gysin, J., & Scherf, A.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Université de la Méditerranée Aix-Marseille II (FR)
- University Hospital Heidelberg (DE)
- Corresponding author
- Scherf, Artur
- Venue
- The EMBO Reports
- Published
- 2005-08-01
- Volume
- 6
- Issue
- 8
- Pages
- 775-781
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1369142
- OpenAlex
- W2155425270
- Cited by
- 201
- References
- 37
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 8 · 2020: 3 · 2019: 8 · 2018: 6 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 4 · 2013: 7 · 2012: 8
- FWCI
- 22.98
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bill and Melinda Gates Foundation
- European Commission
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- Plasmodium falciparum, VAR2CSA, chondroitin sulfate A, cytoadhesion, placental malaria, syncytiotrophoblast, vaccine candidate, pregnancy protection, parasite surface proteins
- MeSH terms
- Animals, Antibodies, Protozoan, Antigenic Variation, Cell Adhesion, Chondroitin Sulfates, Cloning, Molecular, Crossing Over, Genetic, Exons, Female, Multigene Family, Humans, Models, Biological, Models, Genetic, Mutation, Phenotype, Placenta, Plasmids, Plasmodium falciparum, Pregnancy, Protein Binding, RNA, Time Factors, Trophoblasts, Blotting, Southern, Blotting, Northern, Pregnancy Complications, Parasitic, Protozoan Proteins, Genome, Malaria, Falciparum, Genome, Protozoan, CD36 Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.